Molecular heterogeneity in human papillomavirus‐dependent and ‐independent vulvar carcinogenesis
Dorian R.A. Swarts(Amsterdam UMC Location Vrije Universiteit Amsterdam), Maaike C.G. Bleeker(Amsterdam UMC Location Vrije Universiteit Amsterdam), Saskia M. Wilting(Amsterdam UMC Location Vrije Universiteit Amsterdam), Peter J.F. Snijders(Amsterdam UMC Location VUmc), Annina P. van Splunter(Amsterdam UMC Location Vrije Universiteit Amsterdam), Daoud Sie(Amsterdam University Medical Centers), Chris J.L.M. Meijer(Dutch Cancer Society), Daniëlle A.M. Heideman(University Medical Center Groningen), Divera T.M. Pronk(Amsterdam UMC Location Vrije Universiteit Amsterdam), Quirinus J.M. Voorham(Amsterdam UMC Location Vrije Universiteit Amsterdam), Renske D.M. Steenbergen(Amsterdam Neuroscience), Marc van Beurden(Oncode Institute)
Cited by 32
Related Papers
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
|International Journal of Cancer|2010|1.1k
K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
|New England Journal of Medicine|1990|811
Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners
|New England Journal of Medicine|2002|806